Joel Greenblatt’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$315K Sell
4,219
-580
-12% -$42.7K ﹤0.01% 1699
2026
Q2
$307K Sell
4,799
-2,775
-37% -$144K ﹤0.01% 1645
2026
Q1
$365K Buy
7,574
+912
+14% +$40.4K ﹤0.01% 1562
2025
Q4
$275K Buy
6,662
+317
+5% +$12.7K ﹤0.01% 1588
2025
Q3
$246K Sell
6,345
-8,331
-57% -$271K ﹤0.01% 1559
2025
Q2
$406K Buy
+14,676
New +$374K ﹤0.01% 1381

Other funds holding KNSA

Joel Greenblatt's KNSA Position: Q3 2026 in Review

Joel Greenblatt reduced its Kiniksa Pharmaceuticals (KNSA) stake by 12% in Q3 2026, selling an estimated $42.7K and leaving 4,219 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

Joel Greenblatt first reported a position in KNSA in Q2 2025 and has held it in 6 quarters since. The position peaked at $406K in Q2 2025. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Joel Greenblatt held 4,219 shares of Kiniksa Pharmaceuticals worth $315K as of Q3 2026.
  • Joel Greenblatt sold 580 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $42.7K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1699 holding.
  • Joel Greenblatt first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Joel Greenblatt's Kiniksa Pharmaceuticals position peaked at $406K in Q2 2025.
  • 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.